NCT01045824

Brief Summary

The goal of this research is to find out possible susceptible gene(s) in schizophrenic patients with family history and 5-year period functional changes of brain among the members of family, in order to further analysis factors and their interactions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 6, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 11, 2010

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 15, 2010

Status Verified

January 1, 2010

Enrollment Period

6 years

First QC Date

January 6, 2010

Last Update Submit

January 14, 2010

Conditions

Keywords

SchizophreniaDNAMRI

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Schizophrenia family

You may qualify if:

  • Psychiatry doctor diagnosed who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for schizophrenia or schizoaffective disorder, family history, age older than 15 will be recruited for participation in this study. Participants agree and sign informed consent forms will eligible to participate this experiment.
  • c.c blood will be drawn from the participants. 3.Participants need to understand procedures and assays of this experiment. 4.At least one psychiatry doctor interview needed, participants and their family voluntarily join this interview, approximately 30-45min.

You may not qualify if:

  • Participant can not understand procedures and assays of this experiment.
  • Participant has material abuse history, it could seriously influence diagnosis.
  • Participant has combination diseases, it could seriously influence diagnosis.
  • Psychopathy or psychosis can not be categorized in defined group.
  • Other considerations:
  • Participants, age fewer than 20 needs to their deputy guardians (parents) and their own consent altogether.
  • Participants who are inability needs to their deputy guardians (parents) and their own consent altogether.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taichung Veterans General Hospital

Taichung, Taiwan, 40705, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

10-20cc of blood will be drawn for DNA analysis

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Tsuo-Hung Lan, MD., PhD.

    Taichung Veterans General Hospital

    STUDY DIRECTOR
  • Tsuo-Hung Lan, MD.,PhD

    Taichung Veterans General Hospital

    STUDY DIRECTOR

Central Study Contacts

Tsuo-Hung Lan, MD., PhD.

CONTACT

Chin Cheng, MD.

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 6, 2010

First Posted

January 11, 2010

Study Start

January 1, 2008

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

January 15, 2010

Record last verified: 2010-01

Locations